OMB
This article was originally published in The Gray Sheet
Executive Summary
Former Eli Lilly Senior VP-Corporate Strategy & Policy Mitchell ("Mitch") Daniels is confirmed by the Senate Jan. 24 as the next director of the Office of Management & Budget. Prior to Lilly, Daniels served a stint as a partner with the Indianapolis law firm Baker & Daniels (no relation) while serving as president of the Hudson Institute, a conservative think tank (1"The Gray Sheet" Jan. 1, 2001, p. 8)
You may also be interested in...
FDA Indicates Move Towards Voluntary IRB Accreditation System
FDA is expected to implement an institutional review board accreditation system that is voluntary and independent of the agency, but still under its jurisdiction, according to David Lepay, MD/PhD, acting director of the agency's Office of Clinical Science.
FDA Indicates Move Towards Voluntary IRB Accreditation System
FDA is expected to implement an institutional review board accreditation system that is voluntary and independent of the agency, but still under its jurisdiction, according to David Lepay, MD/PhD, acting director of the agency's Office of Clinical Science.
OMB Nominee Daniels Has Chance To Shape Medicare, Indiana Ties
The most important Bush Administration appointment for health care manufacturers is the Dec. 23 nomination of Eli Lilly Senior VP-Corporate Strategy & Policy Mitchell ("Mitch") Daniels as director of the Office of Management & Budget.